Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
03/2000
03/07/2000US6033674 Method of treating cancer with a tumor cell line having modified cytokine expression
03/07/2000US6033673 Double mutant enterotoxin for use as an adjuvant
03/07/2000US6033672 Method of stimulating an immune response to caprine arthritis-encephalitis virus (CAEV) in humans through the administration of CAEV immunogens
03/07/2000US6033671 Identification of human cytomegalovirus genes involved in down-regulation of MHC class I heavy chain expression
03/07/2000US6033670 Recombinant live avian vaccine, using as vector the avian infectious laryngotracheitis virus
03/07/2000US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby
03/07/2000US6033668 Chimeric protein which confers protection against parainfluenza virus and respiratory syncytial virus
03/07/2000CA2013966C Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins
03/07/2000CA1340919C Mouse monoclonal antibodies to hiv-1p24 and their use in diagnostic tests
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011187A1 Molecular sequence of swine retrovirus and methods of use
03/02/2000WO2000011186A1 Modified hcv peptide vaccines
03/02/2000WO2000011183A2 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000WO2000011182A1 Basb024 outer membrane protein of neisseria meningitidis
03/02/2000WO2000011181A1 NUCLEIC ACID MOLECULES ENCODING INCLUSION MEMBRANE PROTEIN C OF $i(CHLAMYDIA)
03/02/2000WO2000011180A1 NUCLEIC ACID MOLECULES ENCODING POMP91A PROTEIN OF $i(CHLAMYDIA)
03/02/2000WO2000011179A1 RECOMBINANT MULTIVALENT MALARIAL VACCINE AGAINST $i(PLASMODIUM FALCIPARUM)
03/02/2000WO2000011172A1 Antithrombin nucleotides and proteins from horn fly
03/02/2000WO2000011163A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000WO2000011140A1 Methods of augmenting mucosal immunity through systemic priming and mucosal boosting
03/02/2000WO2000011036A1 AN ANTI-CYANOVIRIN ANTIBODY WITH AN INTERNAL IMAGE OF gp120, A METHOD OF USE THEREOF, AND A METHOD OF USING A CYANOVIRIN TO INDUCE AN IMMUNE RESPONSE TO gp120
03/02/2000WO2000011035A1 Hiv suppressor factor derived from scrub typhus
03/02/2000WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins
03/02/2000WO2000010609A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010601A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
03/02/2000WO2000010600A2 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
03/02/2000WO2000010599A2 IMMUNOGENIC β-PROPIONAMIDO-LINKED POLYSACCHARIDE PROTEIN CONJUGATE USEFUL AS A VACCINE PRODUCED USING AN N-ACRYLOYLATED POLYSACCHARIDE
03/02/2000WO2000010597A1 Vaccine comprising cytokine-induced heat shock proteins (hsp)
03/02/2000WO2000010595A2 Medicaments for manipulating t-cell immune response
03/02/2000WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
03/02/2000WO2000010585A1 THE COMBINATION OF MOXA CONE AND THE HOMEOPATHIC SPECIFIC OF THE AGENT CREATING IgE TYPE ALLERGY TO TREAT THE MENTIONED ALLERGIES
03/02/2000WO2000010580A2 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
03/02/2000WO2000010555A1 Method of preventing tuberculosis in young cattle
03/02/2000WO1999066879A3 Systemic immune activation method using nucleic acid-lipid complexes
03/02/2000WO1999066049A3 A novel gene and method of treating a gram negative bacterial infection
03/02/2000WO1999064054A9 Multibinding inhibitors of topoisomerase
03/02/2000WO1999064043A9 Muscarinic receptor antagonists
03/02/2000WO1999063945A3 Vaccination strategy to prevent and treat cancers
03/02/2000WO1999063937A3 Multivalent macrolide antibiotics
03/02/2000WO1999063093A3 Basb027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses
03/02/2000WO1999061620A3 Neisseria meningitidis antigenic polypeptides, corresponding polynucleotides and protective antibodies
03/02/2000WO1999061614A3 Human socs proteins
03/02/2000WO1999060124A9 Differentiation-associated sequences and methods of use therefor
03/02/2000WO1999058552A3 Peptides that ellicit t, cellular immunity
03/02/2000WO1999057271A3 Feline cd80, feline cd86, feline cd28, and feline ctla-4 nucleic acid and polypeptides
03/02/2000WO1999057149A3 Compounds and methods for modulating nonclassical cadherin-mediated functions
03/02/2000WO1999055367A9 INTERNALIZING ErbB2 ANTIBODIES
03/02/2000WO1999053945A8 Neuron growth inhibitory molecules or derivatives thereof used to immunize mammals thereby promoting axon regeneration
03/02/2000WO1999052547A9 Vaccine compositions comprising cd-1 antigens and t-cell stimulating compound and methods of use thereof
03/02/2000WO1999045108A3 Novel mechanically sensitive mammal potassium channel family activated by polyunsaturated fatty acids and their use particularly for screening medicines
03/02/2000WO1999045031A3 Cd147 binding molecules as therapeutics
03/02/2000WO1999042596A3 Phosphodiesterase 10
03/02/2000WO1999024578A3 Neisserial antigens
03/02/2000DE19839736A1 Humane monoklonale Antikörper gegen Inselzellantigen IA-2 Human monoclonal antibodies against islet cell antigen IA-2
03/02/2000DE19827457C1 Strukturprotein von AAV, seine Herstellung und Verwendung AAV structural protein, its preparation and use
03/02/2000CA2341742A1 Activation and protection of t-cells (cd4+ and cd8+) using an h2 receptor agonist and other t-cell activating agents
03/02/2000CA2341637A1 Chlamydia antigens and corresponding dna fragments and uses thereof
03/02/2000CA2341586A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000CA2341558A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000CA2341079A1 Basb024 outer membrane protein of neisseria meningitidis
03/02/2000CA2340787A1 An anti-cyanovirin antibody with an internal image of gp120, a method of use thereof, and a method of using a cyanovirin to induce an immune response to gp120
03/02/2000CA2340692A1 Immunogenic .beta.-propionamido-linked polysaccharide protein conjugate useful as a vaccine produced using an n-acryloylated polysaccharide
03/02/2000CA2340466A1 Antithrombotic agent and humanized anti-von willebrand factor monoclonal antibody
03/02/2000CA2340330A1 Nucleic acid molecules encoding inclusion membrane protein c of chlamydia
03/02/2000CA2340305A1 Hiv suppressor factor derived from scrub typhus
03/02/2000CA2340283A1 Nucleic acid molecules encoding pomp91a protein of chlamydia
03/02/2000CA2340281A1 Neural retinal cells and retinal pigment epithelium cells and their use in treatment of retinal disorders
03/02/2000CA2339968A1 Dcr5, a bmp-binding protein, and applications thereof
03/02/2000CA2339036A1 Tpl-2/cot kinase and methods of use
03/02/2000CA2253058A1 Therapeutic composition that produce and immune response
03/01/2000EP0982591A2 Imprints formed using functionally complemetary monomers
03/01/2000EP0982402A1 Pestivirus vaccination
03/01/2000EP0982400A1 Human glycine transporter
03/01/2000EP0981636A1 Lentivirus-based gene transfer vectors
03/01/2000EP0981625A2 $i(ENTEROCOCCUS FAECALIS) POLYNUCLEOTIDES AND POLYPEPTIDES
03/01/2000EP0981624A2 $i(LEISHMANIA) ANTIGENS FOR USE IN THE THERAPY AND DIAGNOSIS OF LEISHMANIASIS
03/01/2000EP0981618A1 Apo-2 RECEPTOR
03/01/2000EP0981550A1 Methods for eosinophil depletion and compositions therefor
03/01/2000EP0981548A1 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof
03/01/2000EP0981547A1 Tumor-associated antigen
03/01/2000EP0981544A2 Anti-bacterial methods and materials
03/01/2000EP0981537A1 An infectious clone for human parainfluenza virus type 3
03/01/2000EP0981370A1 A method of preservation of vaccines with polybiguanide
03/01/2000EP0981369A2 Immunogenic compositions to the cck-b/gastrin-receptor and methods for the treatment of tumors
03/01/2000EP0981367A1 Immunization against endogenous molecules
03/01/2000EP0804230B1 Vaccine against mycobacterial infections
03/01/2000EP0702564B1 Novel attenuated pseudomonas aeruginosa strains
03/01/2000EP0666760B1 VACCINE COMPRISING PART OF CONSTANT REGION OF IgE FOR TREATMENT OF IgE-MEDIATED ALLERGIC REACTIONS
03/01/2000EP0594739B1 Cancer treatment
03/01/2000CN1246158A Method of PCR testing of pooled blood samples
03/01/2000CN1246151A Mutants of streptococcal toxin A and methods of use
03/01/2000CN1246056A Mycobacterium vaccae for down-regulation of THz activity of immune system
03/01/2000CN1245721A Method for preparing intestinal transmitted non-A and non-B hepatitis vaccine
02/2000
02/29/2000US6031080 Chemotactic cytokine
02/29/2000US6031078 MTbx protein and nucleic acid molecules and uses therefor
02/29/2000US6031077 For prevention and treatment of heartworm infections; parasiticides; anthelmintics
02/29/2000US6030945 Apo-2 ligand
02/29/2000US6030835 Methods and composition for identifying group a streptococcus
02/29/2000US6030833 Genetically engineered cell which includes one or more of a human human leukocyte antigen a, b, c, or g transgene; for organ transplants with immunosuppression of human natural killer cell mediated attack
1 ... 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 ... 1823